Studies have shown that β-adrenoreceptors, especially ADRB1 and ADRB2, are highly expressed in pan cancers that significantly reduce the overall survival of tumor patients (Lehrer and Rheinstein, 2020). The gene discussed is ADRB1; the disease is neoplasm.